An FDAnews Webinar
Instem’s submit™-SEND tools and services are the most widely adopted
in the industry, operating at over 80 sites across 15 countries
April 20th – Please read our latest update on how we’re helping clients fight the COVID-19 pandemic.
Bi-weekly blog to provide best-practice insight, observations and opinions to help navigate the challenges and opportunities of SEND
Value-added blog to provide unique industry and regulatory insight and best practice guidance for computational toxicology scientists and professionals
Instem Technology Selected to Streamline Preclinical Operations, Improve Productivity and Ensure SEND Compliance at South Korea’s Largest Preclinical R&D Facility
To help you evaluate systems, we believe that an initial, no-pressure demonstration carried out over the Internet is the way to go.
© 2020 Instem Group of Companies